ASX Dividend Stocks Including Bisalloy Steel Group And Two More

Simply Wall St

As the Australian market faces a potential 0.89% decline at open today, driven by trade concerns from the U.S., investors are keenly observing how these global tensions impact domestic indices like the ASX 200. In such volatile times, dividend stocks can offer a degree of stability and income, making them an attractive option for those looking to navigate economic uncertainties while maintaining portfolio resilience.

Top 10 Dividend Stocks In Australia

NameDividend YieldDividend Rating
IPH (ASX:IPH)7.11%★★★★★☆
Lindsay Australia (ASX:LAU)7.10%★★★★★☆
Bisalloy Steel Group (ASX:BIS)9.10%★★★★★☆
Accent Group (ASX:AX1)6.82%★★★★★☆
Sugar Terminals (NSX:SUG)8.45%★★★★★☆
Super Retail Group (ASX:SUL)8.50%★★★★★☆
MFF Capital Investments (ASX:MFF)3.70%★★★★★☆
Nick Scali (ASX:NCK)3.20%★★★★★☆
Fiducian Group (ASX:FID)4.42%★★★★★☆
Lycopodium (ASX:LYL)7.11%★★★★★☆

Click here to see the full list of 29 stocks from our Top ASX Dividend Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Bisalloy Steel Group (ASX:BIS)

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Bisalloy Steel Group Limited manufactures and sells quenched and tempered, high-tensile, and abrasion-resistant steel plates in Australia, Indonesia, Thailand, and internationally with a market cap of A$169.40 million.

Operations: The company's revenue primarily derives from the production and distribution of high-performance steel plates designed for durability and resistance in various markets, including Australia, Indonesia, Thailand, and beyond.

Dividend Yield: 9.1%

Bisalloy Steel Group's dividend yield of 9.1% places it in the top 25% of Australian dividend payers, although its track record has been volatile over the past decade. Despite this instability, recent dividends are well-covered by earnings (payout ratio: 81.2%) and cash flows (cash payout ratio: 66.6%). The company reported a modest increase in net income for H1 FY2025, alongside an ordinary fully franked dividend declaration of A$0.08 per share for the same period.

ASX:BIS Dividend History as at May 2025

Lycopodium (ASX:LYL)

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Lycopodium Limited offers engineering and project delivery services across the resources, rail infrastructure, and industrial processes sectors in Australia, with a market cap of A$421.25 million.

Operations: Lycopodium Limited's revenue segments include A$347.83 million from Resources, A$10.84 million from Process Industries, and A$10.14 million from Rail Infrastructure.

Dividend Yield: 7.1%

Lycopodium's dividend yield of 7.11% ranks it among the top 25% of Australian dividend payers, though its payout history has been inconsistent over the past decade. Despite this volatility, dividends are well-supported by earnings with a payout ratio of 43.2%, and cash flows cover dividends at an 80.8% cash payout ratio. Recently added to the S&P/ASX Emerging Companies Index, Lycopodium trades at a discount to its estimated fair value by 19.7%.

ASX:LYL Dividend History as at May 2025

Medibank Private (ASX:MPL)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Medibank Private Limited offers private health insurance and health services in Australia, with a market cap of A$13.30 billion.

Operations: Medibank Private Limited generates revenue primarily from its Health Insurance segment, amounting to A$8.06 billion, and Medibank Health services, contributing A$447.10 million.

Dividend Yield: 3.4%

Medibank Private's dividend yield of 3.44% is below the top quartile of Australian dividend payers, with a high payout ratio of 96.7%, indicating dividends are not well-covered by earnings but are supported by cash flows at an 82.6% cash payout ratio. The company has maintained stable and reliable dividends over the past decade, recently increasing its ordinary dividend to A$0.078 per share for the six months ending December 2024 amidst ongoing legal issues from a cybercrime event in 2022.

ASX:MPL Dividend History as at May 2025

Where To Now?

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Lycopodium might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com